TScan Therapeutics
TCRX
TCRX
29 hedge funds and large institutions have $44.4M invested in TScan Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
29
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$450K | |
| 2 | +$240K | |
| 3 | +$219K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$180K |
| 5 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
+$97K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$931K | |
| 3 | -$834K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$221K |
| 5 |
Two Sigma Investments
New York
|
-$190K |